Unclear standard of care for pediatric high grade glioma patients

Journal of Neuro-Oncology

Volumn 113, Issue 2, 2013, Pages 341-342

  Fangusaro, Jason ^a   Warren, Katherine E ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; LOMUSTINE; NITROSOUREA; PREDNISONE; TEMOZOLOMIDE; VINCRISTINE; VORINOSTAT;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; E-MAIL; GLIOMA; HEALTH CARE QUALITY; HUMAN; LETTER; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; PATIENT CARE; PHYSICIAN; PROGRESSION FREE SURVIVAL; QUESTIONNAIRE; RESPONSIBILITY; BRAIN NEOPLASMS; CANCER GRADING; CLINICAL TRIAL (TOPIC); PATHOLOGY; PROGNOSIS;

BRAIN NEOPLASMS; CHILD; CLINICAL TRIALS AS TOPIC; GLIOMA; HUMANS; NEOPLASM GRADING; PROGNOSIS; STANDARD OF CARE;

EID: 84879109497     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1104-8     Document Type: Letter

References (4)

1. Finlay JL et al (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen Childrens Cancer Group. J Clin Oncol 13(1):112-123
2. Cohen KJ et al (2011) Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. Neuro Oncol 13(3):317-323
3. Sposto R et al (1989) The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7(2):165-177
4. Stupp R et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987-996